BioSpace News Archive

Business

Insmed Reports Third Quarter 2017 Financial Results and Provides Business Update

For the third quarter of 2017, Insmed reported a net loss of $45.2 million, or $0.69 per share, compared with a net loss of $37.8 million, or $0.61 per share, for the third quarter of 2016.

November 2, 2017

·

16 min read

Business

PLx Pharma to Discuss 2017 Third Quarter Financial Results on November 10, 2017 Conference Call

Natasha Giordano, President and CEO, and Rita O’Connor, CFO, will host a conference call to discuss the results.

November 2, 2017

·

2 min read

Biotech Bay

goBalto Release: Industry Leader in Study Startup Releases Updated eBook on Starting Clinical Trials

Since its inaugural release, the eBook has been downloaded over 62,000 times.

November 2, 2017

·

2 min read

Business

TCR2 Therapeutics Appoints Cell Therapy Pioneer Dr. Stephan Grupp to Advisory Board

“Dr. Stephan Grupp has helped to revolutionize T cell immunotherapy and we are thrilled to welcome him to TCR2’s Advisory Board,” said Mitchell Finer, PhD, Chairman of TCR2’s Advisory Board and Member of the company’s Board of Directors.

November 2, 2017

·

3 min read

Deals

Allena Pharma Announces Pricing of Initial Public Offering

The company announced the pricing of its initial public offering of 5,333,333 shares of common stock at a public offering price of $14.00 per share.

November 2, 2017

·

2 min read

Policy

scPharma Announces FDA Acceptance of NDA for Furoscix (subcutaneous furosemide)

The NDA for Furoscix has been accepted for filing by the FDA and under the PDUFA, the FDA has set an action date of June 23, 2018.

November 2, 2017

·

1 min read

Drug Development

Concentric Analgesics Launches CA-008 Clinical Development Program in Post-Surgical Pain

Results from this clinical trial are expected in the first quarter of 2018.

November 2, 2017

·

3 min read

Baxter Supports 27 Abstract Presentations at ASN Kidney Week to Advance Scientific Exchange Focused on New Standards of Renal Care

Baxter today announced the presentation of 27 abstracts at the American Association of Nephrology (ASN) Kidney Week, Oct. 31 - Nov. 5, to support greater scientific exchange across the continuum of renal care.

November 2, 2017

·

3 min read

Business

Flex Pharma to Report Third Quarter 2017 Results on November 6, 2017

The Company will host a conference call and webcast at 8:45 a.m. ET to discuss third quarter 2017 financial results and provide a business update.

November 2, 2017

·

1 min read

BioMidwest

DowDuPont Declares Quarterly Dividend of 38 Cents per Share, Announces Initial $4 Billion Share Repurchase Program

DowDuPont’s dividend for the fourth quarter of 2017 will be payable on Dec. 15, 2017, to shareholders of record on Nov. 15, 2017.

November 2, 2017

·

8 min read